Description:
At GSK we see a world in which advanced applications of Machine Learning and AI will allow us to develop novel therapies to existing diseases and to quickly respond to emerging or changing diseases with personalized drugs, driving better outcomes at reduced cost with fewer side effects. It is an ambitious vision that will require the development of products and solutions at the cutting edge of Machine Learning and AI. If that excites you, we'd love to chat.
Our team is focused on accelerating the discovery and development of novel RNA therapeutics. This work explores the exciting potential of applying state-of-the-art machine learning and AI to life sciences and drug discovery. We're looking for an accomplished Machine Learning Engineer to help us make this vision a reality. Strong candidates will have a track record of shipping high performing AI/ML powered products in production environments, and a passion for solving challenging problems in Artificial Intelligence and Machine Learning. Educational or professional background in the biological sciences is a plus but is not necessary; passion to help therapies for new and existing diseases, and a pattern of continuous learning and development is required.
The AI/ML team is built on the principles of ownership, accountability, continuous development, and collaboration. We hire for the long term, and we're motivated to make this a great place to work. Our leaders will be committed to your career and development from day one.
In this role you will
Why you?
Qualifications & Skills:
We are looking for professionals with these required skills to achieve our goals:
Preferred Qualifications & Skills:
If you have the following characteristics, it would be a plus:
Organization | GSK |
Industry | Engineering Jobs |
Occupational Category | Machine Learning Engineer II |
Job Location | London,UK |
Shift Type | Morning |
Job Type | Full Time |
Gender | No Preference |
Career Level | Intermediate |
Experience | 2 Years |
Posted at | 2024-07-09 4:10 pm |
Expires on | 2024-12-16 |